American Journal of Clinical Medicine Research. 2021, 9(1), 14-18
DOI: 10.12691/AJCMR-9-1-4
Original Research

Analysis of Common Pathogenic Bacteria and Drug Resistance of Biliary Tract Infection in Nanjing Area

Rui-Xia Yang1 and Wei-Juan Song1,

1Department of Laboratory Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

Pub. Date: January 31, 2021

Cite this paper

Rui-Xia Yang and Wei-Juan Song. Analysis of Common Pathogenic Bacteria and Drug Resistance of Biliary Tract Infection in Nanjing Area. American Journal of Clinical Medicine Research. 2021; 9(1):14-18. doi: 10.12691/AJCMR-9-1-4

Abstract

Background: Analyze the distribution and drug resistance of pathogenic bacteria that cause biliary tract infections in Nanjing, and provide evidence for the rational use of antibacterial drugs in clinical practice. Methods: Clinical strains isolated from bile specimens of patients suspected of biliary infection in the First Affiliated Hospital of Nanjing Medical University in 2019 were collected, The drug susceptibility criteria are based on the standards published by the National Standardization Committee of the US Clinical Laboratories. WHONET 5.6 software was used to analyze the distribution of pathogens and drug resistance. Results: A total of 693 strains of pathogenic bacteria were isolated, including 448 Gram-negative bacteria(64.6%), 245 Gram-positive bacteria (35.4%). The top three pathogens were 210 strains of Escherichia coli(30.3%), 87 strains of enterococcus faecium (12.6%), 76 strains of klebsiella pneumoniae (11.0%), The resistance rates of Escherichia coli to ampicillin, cefuroxime, cefazolin, ceftriaxone, piperacillin and ampicillin / sulbactam were 80.1%, 69.4%, 67.3%, 64.1%, 63.6% and 62.8%, The resistance rates of Klebsiella pneumoniae to ampicillin / sulbactam, cefuroxime and cefazolin were 65.8%, 64.5% and 61.1%, The resistance rates of Enterobacter cloacae to ceftriaxone, ceftazidime and aztreonam were 56.2%, 53.1% and 53.1%, The resistance rates of Enterococcus faecium to moxifloxacin, clindamycin, erythromycin, penicillin G, ampicillin, ciprofloxacin and levofloxacin were 100%, 90%, 76%, 72.1%, 64.4%, 64% and 62%. Conclusions: Pathogens of biliary tract infections are mainly Enterobacteriaceae such as Escherichia coli and Klebsiella pneumoniae, followed by Enterococcus faecium and Enterococcus faecalis. There were many drug-resistant bacteria, so we should pay attention to bile specimen culture and drug sensitivity test.

Keywords

Biliary tract infection, pathogenic bacteria, drug resistance, Nanjing

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Sokal A, Sauvanet A, Fantin B, etal. Acute cholangitis: Diagnosis and management. J Visc Surg, 2019, 156(6): 515-525.
 
[2]  Sulzer JK, Ocuin LM. Cholangitis: Causes, Diagnosis, and Management. Surg Clin North Am, 2019, 99(2): 175-184.
 
[3]  Kochar R, Banerjee S. Infections of the biliary tract. Gastrointest Endosc Clin N Am, 2013, 23(2):199-218.
 
[4]  ZY Wu, XS Wu, WY Yao, etal. Pathogens' distribution and changes of antimicrobial resistance in the bile of acute biliary tract infection patients, Zhonghua Wai Ke Za Zhi. 2021, 59(1): 24-31.
 
[5]  Zhao J, Wang Q, Zhang J. Changes in Microbial Profiles and Antibiotic Resistance Patterns in Patients with Biliary Tract Infection over a Six-Year Period, Surg Infect (Larchmt). 2019, 20(6): 480-485.
 
[6]  Gu XX, Zhang MP, Zhao YF, etal. Clinical and microbiological characteristics of patients with biliary disease, World J Gastroenterol. 2020, 26(14):1638-1646.
 
[7]  Trine Langfeldt Hagen, Mathias Amdi Hertz, Gábor Balázs Uhrin, etal. Adherence to local antimicrobial guidelines for initial treatment of community-acquired infections, Dan Med J. 2017, 64(6): A5381.
 
[8]  Lu BR, Mack CL. Inflammation and biliary tract injury, Curr Opin Gastroenterol. 2009, 25(3): 260-264.
 
[9]  Reddy KR. Infections of the Liver and Biliary System, Gastroenterol Clin North Am. 2020, 49(2): xv-xvi.
 
[10]  Artur Pasternak, Miroslaw Szura, Krzysztof Gil, etal. Metabolism of bile with respect to etiology of gallstone disease - systematic review, Folia Med Cracov. 2014; 54(2): 5-16.
 
[11]  Keishi Sugimachi, Tomohiro Iguchi, Yohei Mano, etal. Significance of bile culture surveillance for postoperative management of pancreatoduodenectomy, World J Surg Oncol . 2019, 17(1): 232.
 
[12]  Kwon JS, Han J, Kim TW, etal. Changes in causative pathogens of acute cholangitis and their antimicrobial susceptibility over a period of 6 years, Korean J Gastroenterol. 2014, 63(5): 299-307.
 
[13]  Park JW, Lee JK, Lee KT, etal. How to interpret the bile culture results of patients with biliary tract infections.
 
[14]  Y Edlund. Bacteriology in biliary tract infection and the effect of sulphonamide treatment, Rev Int Hepatol . 1965; 15(4): 721-30.
 
[15]  L BEIQUE, P CHALUT. Treatment of biliary tract calculi and infection, Union Med Can. 1957, 86(4): 394-402.